SEQUENCING VIA ION-TRAP/TIME-OF-FLIGHT MASS SPECTROMETRY

通过离子阱/飞行时间质谱进行测序

基本信息

  • 批准号:
    2208964
  • 负责人:
  • 金额:
    $ 13.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-09-01 至 1995-08-31
  • 项目状态:
    已结题

项目摘要

We propose to develop new methodology for the rapid sequencing of DNA, involving a combination of biochemical methods and mass spectroscopic analysis. This will involve using mass analysis to sequence the DNA fragments produced by the Sanger method rather than gel electrophoretic techniques. The sequence is encoded in the mass of the DNA strands produced, which can be rapidly separated and identified based upon electrostatic acceleration in a time-of-flight device. Using this methodology it is estimated that at least 50 K bases can be sequenced per day with a desired ultimate goal of 200 K bases per day. This sequencing rate will be based upon matrix-assisted laser desorption/ionization (MALDI) of DNA strands of at least 200 base pairs which can be mass resolved and identified and a multisample desorption probe which will provide rapid sample throughout. In order to enhance the sensitivity of the method to detect the low femtomolar levels of each DNA strand available from biochemical degradation, ion trap storage technology will be interfaced to a reflection time-of-flight device. In addition, the ion trap storage method will be essential for attaining sufficient resolution for the highly energetic ions produced by the MALDI process. Ultimately, a key issue to be explored in this work will involve the development of methods for volatilization and ionization of DNA using MALDI from liquid or solid doped matrices which will be studied and optimized for these experiments.
我们建议开发新的方法来快速测序DNA,

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Lubman其他文献

Su1878 - Serum Markers can Predict Future Fibrostenotic Complications at the Time of Diagnosis in Pediatric Crohn's Disease
  • DOI:
    10.1016/s0016-5085(18)32224-8
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jing Wu;David M. Lubman;Subra Kugathasan;Lee A. Denson;Jeffrey S. Hyams;Marla Dubinsky;Anne M. Griffiths;Robert N. Baldassano;Joshua D. Noe;Wallace V. Crandall;Peter D. Higgins;Ryan W. Stidham
  • 通讯作者:
    Ryan W. Stidham
The role of emN/em-glycosylation in cancer
N-糖基化在癌症中的作用
  • DOI:
    10.1016/j.apsb.2023.10.014
  • 发表时间:
    2024-03-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Yu Lin;David M. Lubman
  • 通讯作者:
    David M. Lubman

David M. Lubman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Lubman', 18)}}的其他基金

Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein Markers
用于外泌体蛋白标记物可重复准确定量的通用内标
  • 批准号:
    10358672
  • 财政年份:
    2022
  • 资助金额:
    $ 13.39万
  • 项目类别:
Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein Markers
用于外泌体蛋白标记物可重复准确定量的通用内标
  • 批准号:
    10551223
  • 财政年份:
    2022
  • 资助金额:
    $ 13.39万
  • 项目类别:
Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease
筛选血清中的聚糖标记物以早期检测不同病因的 HCC
  • 批准号:
    9893836
  • 财政年份:
    2018
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    10447725
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    8825456
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    10657544
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    8296170
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Supplemental for Detection of Glycopeptides of MCI in Patient Serum
用于检测患者血清中 MCI 糖肽的补充品
  • 批准号:
    10492874
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    10285013
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach
使用质谱方法检测早期肝细胞癌的血清糖标记物
  • 批准号:
    8464671
  • 财政年份:
    2012
  • 资助金额:
    $ 13.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了